J
Jifa Zhang
Researcher at Sichuan University
Publications - 52
Citations - 496
Jifa Zhang is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 4, co-authored 12 publications receiving 84 citations.
Papers
More filters
Journal ArticleDOI
Targeting autophagy-related protein kinases for potential therapeutic purpose.
TL;DR: The role of some autophagy-related kinase targets and kinase-mediated phosphorylation mechanisms in autophagic regulation is described and the small-molecule kinase inhibitors/activators of these targets are summarized, highlighting the opportunities of these new therapeutic agents.
Journal ArticleDOI
Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development
TL;DR: In this article, the authors summarize the latest protein characteristics and biological functions of BRD4 as an example of BET proteins, analyze the clinical development status and preclinical resistance mechanisms, and discuss recent advances in BRD 4-selective inhibitors, dual-target BET inhibitors, proteolysis targeting chimera degraders, and protein-protein interaction inhibitors.
Journal ArticleDOI
Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy
Chengcan Yang,Jifa Zhang,Minru Liao,Yushang Yang,Yuxi Wang,Yong Yuan,Liang Ouyang,Liang Ouyang +7 more
TL;DR: Current understanding of the functions of folate-metabolizing enzymes, especially SHMT2 and MTHFD2, are outlined, discussing their expression, potential functions, and regulatory mechanism in cancers.
Journal ArticleDOI
Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery.
TL;DR: A review of strategies targeting lysosomal pathways and Lysosome-based degradation techniques are summarized in this article, and the advantages and challenges of Lysosomes-based degrading drugs are described.
Journal ArticleDOI
Emerging strategies to overcome resistance to third-generation EGFR inhibitors
TL;DR: In this paper , the authors discuss the molecular mechanisms of resistance to third-generation EGFR inhibitors and review recent strategies for overcoming resistance, new challenges, and future development directions, and discuss several strategies to overcome resistance.